Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Other Non Operating Income of $107000.0 for Q1 2026, up 153.77% on a YoY basis from $42164.4 in Q1 2025, and up 2775.0% quarter-over-quarter from -$4000.0 in Q4 2025.
Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Other Non Operating Income for 5 years, with the latest figure at $107000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 153.77% year-over-year to $107000.0; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 219.19% YoY), and the FY2025 full-year result was $700000.0, up 200.0% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $107000.0, up from -$4000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $745000.0 in Q2 2025, with the low at -$1.0 million in Q3 2024.
- Historically, Other Non Operating Income has averaged $25888.9 across 3 years, with a median of $101000.0 in 2024.
- The largest YoY upside for Other Non Operating Income was 637.62% in 2025 against a maximum downside of 380.28% in 2025.
- Bicycle Therapeutics' Other Non Operating Income stood at $254000.0 in 2024, then slumped by 101.57% to -$4000.0 in 2025, then soared by 2775.0% to $107000.0 in 2026.
- The last three Other Non Operating Income figures came in at $107000.0 (Q1 2026), -$4000.0 (Q4 2025), and $158000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 745,000.00 |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | 254,000.00 |
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | 101,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Jun 30, 2019 | -2.18 Mn |
| Mar 31, 2019 | -3.19 Mn |
| Dec 31, 2018 | 807,000.00 |
| Sep 30, 2018 | -1.36 Mn |
| Jun 30, 2018 | -73,000.00 |